Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Cisplatin and Docetaxel Followed by Concurrent Docetaxel/RT with Amifostine for HNSCC
NCT00318890Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2002
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Alabama at Birmingham. Started Oct 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00318890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318890.